Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

WIN 2016

27 - 28 Jun 2016
Hotel Novotel Paris Eiffel Tower, Paris, France
Monitoring the cancer genome in plasma using circulating tumour DNA
Dr Nitzan Rosenfeld - Cancer Research UK Cambridge Institute, Cambridge, UK
Monitoring the cancer genome in plasma using circulating tumour DNA ( Dr Nitzan Rosenfeld - Cancer Research UK Cambridge Institute, Cambridge, UK )
5 Jul 2016
Models and critical preclinical data shaping personal therapy
Prof Brian Leyland-Jones - Avera McKennan Cancer Institute, Sioux-Falls, USA
Models and critical preclinical data shaping personal therapy ( Prof Brian Leyland-Jones - Avera McKennan Cancer Institute, Sioux-Falls, USA )
5 Jul 2016
Cancer organoids
Dr Robert Vries - Hubrecht Organoid Technology, Utrecht, The Netherlands
Cancer organoids ( Dr Robert Vries - Hubrecht Organoid Technology, Utrecht, The Netherlands )
5 Jul 2016
Serum miRNAs as diagnostic tools in GI malignancies
Dr Ajay Goel - Baylor University Medical Center, Waco, USA
Serum miRNAs as diagnostic tools in GI malignancies ( Dr Ajay Goel - Baylor University Medical Center, Waco, USA )
4 Jul 2016
Combination trial designs: efficient, effective and tolerable regimens
Dr Susan Galbraith – AstraZeneca, Macclesfield, UK
Combination trial designs: efficient, effective and tolerable regimens ( Dr Susan Galbraith – AstraZeneca, Macclesfield, UK )
4 Jul 2016
Patient perspectives in precision medicine: 'No innovation about us without us'
Dr Francesco de Lorenzo - European Cancer Patient Coalition, Brussels, Belgium
Patient perspectives in precision medicine: 'No innovation about us without us' ( Dr Francesco de Lorenzo - European Cancer Patient Coalition, Brussels, Belgium )
4 Jul 2016
Liquid biopsies to track clonal evolution and resistance in mCRC
Dr Alberto Bardelli - Candiolo Cancer Institute, Turin, Italy
Liquid biopsies to track clonal evolution and resistance in mCRC ( Dr Alberto Bardelli - Candiolo Cancer Institute, Turin, Italy )
4 Jul 2016
Preclinical strategies for precision medicine in colorectal cancer
Dr Livio Trusolino - Candiolo Cancer Institute, Turin, Italy
Preclinical strategies for precision medicine in colorectal cancer ( Dr Livio Trusolino - Candiolo Cancer Institute, Turin, Italy )
4 Jul 2016
WIN 2016 highlights: Emerging technologies
Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spai...
WIN 2016 highlights: Emerging technologies ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
4 Jul 2016
Critique of the SHIVA trial
Dr Razelle Kurzrock - University of California, San Diego, USA
Critique of the SHIVA trial ( Dr Razelle Kurzrock - University of California, San Diego, USA )
4 Jul 2016
SURVIVEiT supporting patient engagement and care
Matt Ellefson - Founder/CEO, SURVIVEiT, USA
SURVIVEiT supporting patient engagement and care ( Matt Ellefson - Founder/CEO, SURVIVEiT, USA )
4 Jul 2016
Personalising breast cancer therapy
Dr Funda Meric-Bernstam - University of Texas MD Anderson Cancer Center, Houston...
Personalising breast cancer therapy ( Dr Funda Meric-Bernstam - University of Texas MD Anderson Cancer Center, Houston, USA )
4 Jul 2016
Affordable next generation sequencing to support decision making
Dr Elaine Mardis - Washington University, St Louis, USA
Affordable next generation sequencing to support decision making ( Dr Elaine Mardis - Washington University, St Louis, USA )
1 Jul 2016
Characterisation of somatic mutations using patient RNASeq profiles
Prof Andrea Califano - Columbia University Medical Center, New York, USA
Characterisation of somatic mutations using patient RNASeq profiles ( Prof Andrea Califano - Columbia University Medical Center, New York, USA )
1 Jul 2016
WIN 2016 highlights: Changing the understanding of cancer
Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncolog...
WIN 2016 highlights: Changing the understanding of cancer ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
1 Jul 2016
Results of the MINDACT clinical trial
Dr Suzette Delaloge - Institut Gustave Roussy, Paris, France
Results of the MINDACT clinical trial ( Dr Suzette Delaloge - Institut Gustave Roussy, Paris, France )
1 Jul 2016
Systems thinking in the future of personalised medicine
Prof Leroy Hood - Systems Biology, Seattle, USA
Systems thinking in the future of personalised medicine ( Prof Leroy Hood - Systems Biology, Seattle, USA )
1 Jul 2016
Precision cancer medicine in Korea
Dr Chang-Sik Yu - ASAN Medical Center, Seoul, Korea
Precision cancer medicine in Korea ( Dr Chang-Sik Yu - ASAN Medical Center, Seoul, Korea )
1 Jul 2016
New targets in personalised therapy for patients with lung cancer
Prof Bruce Johnson - Dana-Farber Cancer Institute, Bethesda, USA
New targets in personalised therapy for patients with lung cancer ( Prof Bruce Johnson - Dana-Farber Cancer Institute, Bethesda, USA )
1 Jul 2016
WIN 2016: Preview of themes
Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spai...
WIN 2016: Preview of themes ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
22 Apr 2016
WIN 2016: Preview of Speakers
Dr John Mendelsohn - Chairman of the WIN Consortium
WIN 2016: Preview of Speakers ( Dr John Mendelsohn - Chairman of the WIN Consortium )
22 Apr 2016